DNA fragmentation and cell cycle arrest: a hallmark of apoptosis induced by Ruta graveolens in human colon cancer cells

Shagun Arora; Simran Tandon

doi:10.1016/j.homp.2014.10.001

Homeopathy, Inhaltsverzeichnis

Homeopathy 2015; 104(01): 36-47
DOI: 10.1016/j.homp.2014.10.001

Original Paper

DNA fragmentation and cell cycle arrest: a hallmark of apoptosis induced by Ruta graveolens in human colon cancer cells

Authors

Shagun Arora
Simran Tandon

Verantwortlicher Herausgeber dieser Rubrik:

Abstract

In the present study, we investigated the anti-cancer effect of various potencies of Ruta graveolens (Ruta) on COLO-205 cell line, as evidenced by cytotoxicity, migration, clonogenecity, morphological and biochemical changes and modification in the levels of genes associated with apoptosis and cell cycle. On treatment of COLO-205 cells maximal effects were seen with mother tincture (MT) and 30C potencies, wherein decrease in cell viability along with reduced clonogenecity and migration capabilities were noted. In addition morphological and biochemical alterations such as nuclear changes (fragmented nuclei with condensed chromatin) and DNA ladder-like pattern (increased amount of fragmented DNA) in COLO-205 cells indicating apoptotic related cell death were seen. The expression of apoptosis and cell-cycle related regulatory genes assessed by reverse transcriptase-PCR revealed an up-regulation of caspase 9, caspase-3, Bax, p21 and p27 expression and down-regulation of Bcl-2 expression in treated cells. The mode of cell death was suggestive of intrinsic apoptotic pathway along with cell cycle arrest at the G2/M of the cell cycle. Our findings indicate that phytochemicals present in Ruta showed potential for natural therapeutic product development for colon carcinoma.

Keywords

Ruta - Apoptosis - Cell cycle arrest - GC–MS

Volltext

Referenzen

References
1 Globocan colorectal cancer estimated incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
2 Moongkarndi P., Kosem N., Kaslungka S., Luanratana O., Pongpan N. Antiproliferation, antioxidation and induction of apoptosis by Garcinia Mangostona (Mangosteen) On Skbr3 Human Breast Cancer Cell Line. J Ethnopharmacol 2004; 90: 161-166.
3 Hahnemann S. Organon of medicine. 6th edn JP Tarcher, Inc.; Los Angeles: 1982.
4 Downer S.M., Cody M.M., McCluskey P. et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. Br Med J 1994; 309: 86-89.
5 Banerji P., Campbell D.R., Banerji P. Cancer patients treated with the Banerji protocols utilising homoeopathic medicine: a best case series program of the National Cancer Institute USA. Oncol Reports 2008; 20 (01) 69-74.
6 Parray S.A., Bhat J.U., Ahmad G., Jahan N., Sofi G., Iqbal S.M. Ruta graveolens: from traditional system of medicine to modern pharmacology: an overview. Am J PharmTech Res 2012; 2 (02) 1-14.
7 Diwan R., Shinde A., Malpathak N. Phytochemical composition and antioxidant potential of Ruta graveolens L. In Vitro culture lines. J Bot 2012; 2012: 1-7.
8 Pathak S., Multani A.S., Banerji P., Banerji P. Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: a novel treatment for human brain cancer. Int J Oncol 2003; 2003 (23) 975-982.
9 Preethi K., Kuttan G., Kuttan R. Anti-tumour activity of Ruta Graveolens Extract. Asian Pac J Cancer Prev 2006; 7: 439-443.
10 Kumar K.B., Sunila E.S., Kuttan G., Preethi K.C., Venugopal C.M., Kuttan R. Inhibition of chemically induced carcinogenesis by drugs used in homeopathic medicine. Asian Pac J Cancer Prev 2007; 8: 98-102.
11 Preethi K.C., Nair C.K., Kuttan R. Clastogenic potential of Ruta graveolens extract and a homeopathic preparation in mouse bone marrow cells. Asian Pac J Cancer Prev 2008; 9: 763-769.
12 Fadlalla K., Watson A., Yehualaeshet T., Turner T., Samuel T. Ruta Graveolens extract induces dna damage pathways and blocks Akt activation to inhibit cancer cell proliferation and survival. Anticancer Res 2011; 31 (01) 233-241.
13 Réthy B., Zupkó I., Minorics R., Hohmann J., Ocsovszki I., Falkay G. Investigation of cytotoxic activity on human cancer cell lines of arborinine and furanoacridones isolated from Ruta graveolens . Planta Medica 2007; 73: 41-48.
14 Arora S., Aggarwal A., Singla P., Jyoti S., Tandon S. Anti-proliferative effects of homeopathic medicines on human kidney, colon and breast cancer cells. Homeopathy 102 2013; 274-282.
15 Arora S., Tandon S., Tandon C. Evaluation of the cytotoxic effects of CAM therapies: An in vitro study in normal kidney cell line. World Sci J 2014; 2014: 1-11.
16 Roudkenar M., Halabian R., Roushandeh A. et al. Lipocalin 2 regulation by thermal stresses: protective role of Lcn2/NGAL against cold and heat stresses. Exp Cell Res 2009; 315: 3140-3151.
17 Monga J., Pandit S., Chauhan C., Sharma M. Cytotoxicity and apoptosis induction in human breast adenocarcinoma MCF-7cells by (+)-cyanidan-3-ol. Exp Toxicol Pathology 2013; 65: 1-19.
18 Manoj J., Kumar T., Varghese S., Murugan K. The effect of methanol and water extract of Leucobryum bowringii Mitt on growth, migration and invasion of MCF-7 human breast cancer cell lines in vitro”. Indian J Exp Biol 2012; 50: 602-611.
19 Kim A., Im M., Yim N., Jung Y., Ma J. Aqueous extract of Bambusae Caulis in taeniam inhibits PMA-induced tumor cell invasion and pulmonary metastasis: suppression of NF-kB activation through ROS signaling. Plosone 2013; 8: 1-13.
20 Franken N., Rodermond H., Stap J., Haveman J., Bree C. Clonogenic assay of cells: in vitro. Nat Protoc 2006; 1 (05) 2315.
21 Allen J., Sotos M., Sylte J., Czuprynsk C.J. Use of Hoechst 33342 staining to detect apoptotic changes in bovine mononuclear phagocytes infected with Mycobacterium Avium subsp. paratuberculosis. Clin Diagnostic Laboratory Immunol 2001; 8 (02) 460-464.
22 Silva M.S., Filho J.M., Anazetti M.C. et al. Xylodiol from Xylopia langsdorfiana induces apoptosis in HL60 cells. Braz J Pharmacogn 2011; 21 (06) 1035-1042.
23 Zinadah O.A., Khalil W.K., Ashmaoui H.M., Abdul F., Alsoud M.E. Evaluation of the anti-genotoxicity and growth performance impacts of green algae on Mugil cephalus . Life Sci J 2013; 10 (03) 1543-1554.
24 Azizi E., Abdolmohammadi M.H., Fouladdel S., Shafiee A., Amin G., Ghaffari S. Evaluation of p53 and Bcl-2 genes and proteins expression in human breast cancer T47D cells treated with extracts of Astrodaucus persicus (Boiss.) drude in comparison to Tamoxifen. Daru 2009; 17 (03) 181-186.
25 Choi S.C., Kim K.D., Kim J.T. et al. Expression of human NDRG2 by myeloid dendritic cells inhibits down-regulation of activated leukocyte cell adhesion molecule (ALCAM) and contributes to maintenance of T cell stimulatory activity. J Leukoc Biol 2008; 83 (01) 89-98.
26 Tsuan H.Y., Lu C., Yang J.S. et al. Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells. Anticancer Res 2009; 29: 4063-4070.
27 Shang L.H., Mei Li C., Yang Yang Z., Che D.H., Cao J.Y., Yu Y. Luffa echinata Roxb induces human colon cancer cell (HT-29) death by triggering the mitochondrial apoptosis pathway. Molecules 2012; 17: 5780-5794.
28 Ling Q., Xu X., Wei X. et al. Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome C. J Exp Clin Cancer Res 2013; 30: 66.
29 Pozarowski P and Darzynkiewicz Z. Methods in Molecular Biology: Checkpoint Controls and Cancer, Activation and Regulation Protocols”. Humana Press Inc., 281(2):303.
30 Guzman M. Cannabinoids: potential anticancer agents. Nat Rev Cancer 2003; 3: 745-755.
31 Naser B., Bodinet C., Tegtmeier M., Lindequist U. Thuja occidentalis (Arbor vitae): a review of its pharmaceutical, pharmacological and clinical properties. Evidence Based Complementary Altern Med 2005; 2: 69-78.
32 Moghde A., Gangal S., Shilkar S. In vitro cytotoxicity of bryonia laciniosa. Naud. on human cancer cells. Indian J Nat Prod Resour 2011; 2: 322-329.
33 Biswas R., Mandal S., Dutta S. et al. Thujone-rich fraction of Thuja occidentalis demonstrates major anti-cancer potentials: evidences from In Vitro studies on A375 cells. Evidence Based Complementary Altern Med 2011; 2011: 1-16.
34 Yang H., Chen C., Chang W. et al. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata . Cancer Lett 2006; 23: 215-227.
35 Shukla Y., Singh M. Cancer preventive properties of ginger: a brief review. Food Chem Toxicol 2007; 45: 683-690.
36 Ghosh S., Bishayee K., Khuda-Bukhsh A.R. Graveoline isolated from ethanolic extract of Ruta graveolens triggers apoptosis and autophagy in skin melanoma cells: a novel apoptosis-independent autophagic signaling pathway. Phytotherapy Res 2013; 2013: 1-10.
37 Cheng E., Kirsch D., Clem R.J. et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997; 278: 1966-1968.
38 Leung L.K., Wang T.T. Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7. Breast Cancer Res Treat 1999; 55: 73-83.
39 Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
40 Hoyt M.A. A new checkpoint takes shape. Nat Cell Biol 2004; 6: 801-803.
41 Wang Y, Ji P, Liu J, et al. Centrosome-associated regulators of the G (2)/M checkpoint as targets for cancer therapy. Mol Cancer 2009; 8(8).
42 Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?. Trends Cell Biol 2003; 13: 65-70.
43 Wang Y., Hong C., Zhou C., Xu D., Qu H. Screening antitumor compounds psoralen and isopsoralen from Psoralea corylifolia L. Seeds. Evidence Based Complementary Altern Med 2011; 2011: 1-7.
44 Gallo M.B., Sarachine M.J. Biological activities of Lupeol. Int J Biomed Pharm Sci 2009; 3: 46-66.
45 Licchetta A., Correale P., Migali C. et al. Oral metronomic chemo-hormonal-therapy of metastatic breast cancer with cyclophosphamide and megestrol acetate. J Chemother 2010; 22: 201-204.